These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 28695752)

  • 21. State-of-the-art strategies for targeting protein-protein interactions by small-molecule inhibitors.
    Sheng C; Dong G; Miao Z; Zhang W; Wang W
    Chem Soc Rev; 2015 Nov; 44(22):8238-59. PubMed ID: 26248294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulators of 14-3-3 Protein-Protein Interactions.
    Stevers LM; Sijbesma E; Botta M; MacKintosh C; Obsil T; Landrieu I; Cau Y; Wilson AJ; Karawajczyk A; Eickhoff J; Davis J; Hann M; O'Mahony G; Doveston RG; Brunsveld L; Ottmann C
    J Med Chem; 2018 May; 61(9):3755-3778. PubMed ID: 28968506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An overview of late-stage functionalization in today's drug discovery.
    Moir M; Danon JJ; Reekie TA; Kassiou M
    Expert Opin Drug Discov; 2019 Nov; 14(11):1137-1149. PubMed ID: 31411499
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area.
    Ran X; Gestwicki JE
    Curr Opin Chem Biol; 2018 Jun; 44():75-86. PubMed ID: 29908451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening-based approaches to identify small molecules that inhibit protein-protein interactions.
    Choi S; Choi KY
    Expert Opin Drug Discov; 2017 Mar; 12(3):293-303. PubMed ID: 28067063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hot spot-based design of small-molecule inhibitors for protein-protein interactions.
    Guo W; Wisniewski JA; Ji H
    Bioorg Med Chem Lett; 2014 Jun; 24(11):2546-54. PubMed ID: 24751445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benchmark Study Based on 2P2I
    Wang Z; Kang Y; Li D; Sun H; Dong X; Yao X; Xu L; Chang S; Li Y; Hou T
    J Phys Chem B; 2018 Mar; 122(9):2544-2555. PubMed ID: 29420886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small-molecule protein-protein interaction inhibitors: therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations.
    Buchwald P
    IUBMB Life; 2010 Oct; 62(10):724-31. PubMed ID: 20979208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developing a drug-like natural product library.
    Quinn RJ; Carroll AR; Pham NB; Baron P; Palframan ME; Suraweera L; Pierens GK; Muresan S
    J Nat Prod; 2008 Mar; 71(3):464-8. PubMed ID: 18257534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methods for the elucidation of protein-small molecule interactions.
    McFedries A; Schwaid A; Saghatelian A
    Chem Biol; 2013 May; 20(5):667-73. PubMed ID: 23706633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using natural products for drug discovery: the impact of the genomics era.
    Zhang MM; Qiao Y; Ang EL; Zhao H
    Expert Opin Drug Discov; 2017 May; 12(5):475-487. PubMed ID: 28277838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expanding the medicinally relevant chemical space with compound libraries.
    López-Vallejo F; Giulianotti MA; Houghten RA; Medina-Franco JL
    Drug Discov Today; 2012 Jul; 17(13-14):718-26. PubMed ID: 22515962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rationally Designed Semisynthetic Natural Product Analogues for Stabilization of 14-3-3 Protein-Protein Interactions.
    Andrei SA; de Vink P; Sijbesma E; Han L; Brunsveld L; Kato N; Ottmann C; Higuchi Y
    Angew Chem Int Ed Engl; 2018 Oct; 57(41):13470-13474. PubMed ID: 30025189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small molecules, big targets: drug discovery faces the protein-protein interaction challenge.
    Scott DE; Bayly AR; Abell C; Skidmore J
    Nat Rev Drug Discov; 2016 Aug; 15(8):533-50. PubMed ID: 27050677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selectivity via Cooperativity: Preferential Stabilization of the p65/14-3-3 Interaction with Semisynthetic Natural Products.
    Wolter M; de Vink P; Neves JF; Srdanović S; Higuchi Y; Kato N; Wilson A; Landrieu I; Brunsveld L; Ottmann C
    J Am Chem Soc; 2020 Jul; 142(27):11772-11783. PubMed ID: 32501683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity-based protein profiling for natural product target discovery.
    Krysiak J; Breinbauer R
    Top Curr Chem; 2012; 324():43-84. PubMed ID: 22025071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-based evolution of a promiscuous inhibitor to a selective stabilizer of protein-protein interactions.
    Sijbesma E; Visser E; Plitzko K; Thiel P; Milroy LG; Kaiser M; Brunsveld L; Ottmann C
    Nat Commun; 2020 Aug; 11(1):3954. PubMed ID: 32770072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural products as leads to potential drugs: an old process or the new hope for drug discovery?
    Newman DJ
    J Med Chem; 2008 May; 51(9):2589-99. PubMed ID: 18393402
    [No Abstract]   [Full Text] [Related]  

  • 39. Target-oriented and diversity-oriented organic synthesis in drug discovery.
    Schreiber SL
    Science; 2000 Mar; 287(5460):1964-9. PubMed ID: 10720315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and screening of small-molecule α-helix mimetic libraries targeting protein-protein interactions.
    Moon H; Lim HS
    Curr Opin Chem Biol; 2015 Feb; 24():38-47. PubMed ID: 25461722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.